FHRX Insider Trading Activity and SEC Form 4 Filings
FHRX insider trading summary
No open-market insider purchases or sales of First Horizon Pharmaceutical Corp (FHRX) have been reported on SEC Form 4 in the past 12 months.
Latest FHRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 16, 2006 | John N Kapoor | Director | Sell | $23.6M (1,000,000 @ $23.55) |
| May 16, 2006 | Darrell Borne | CFO | Sell | $1.1M (45,625 @ $23.50) |
| May 16, 2006 | Patrick Fourteau | CEO & President | Sell | $2.5M (105,000 @ $23.50) |
| Mar 21, 2006 | John N Kapoor | Director | Sell | $44.6M (2,000,000 @ $22.28) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.